UTREYSA

Details for Australian Trade Mark No. 1333369 (hide)

Owner Merck Sharp & Dohme Corp.

Convention US 9 July 2009 77777694

IR Number 1018825

Various Convention priority claimed: 9 July 2009, United States of America, No. 77777694 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DIABETES, CARDIOVASCULAR DISEASES AND DISORDERS, DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, CANCER,

Filing Date 28 October 2009

Classes

Class 5 Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, musculoskeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, and vaccine preparations

Event Publications

17 December 2009 Application filed

17 December 2009 Application Accepted

8 April 2010 Trade Mark Registered/Protected

8 April 2010 Application/IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1333370-INTREANT

1333368